Zevalin, Biogen Idec’s cancer treatment, was known to be dangerous when it was released on the market. The FDA (Food and Drug Administration) required a black box warning, the highest level of warning, for potentially fatal infusion reactions known to be caused by the Zevalin regimen.
Because this danger was known and users were warned about it, these infusion reactions have not been the basis for Zevalin lawsuits against the manufacturer, though an infusion reaction might be the basis of a medical malpractice lawsuit if the medication was used negligently by a health care professional.
The laws in most states allow people who have been injured by prescription drugs and did not know about the dangers of the drug to file lawsuits against the manufacturer of the drug to recover damages. This kind of Zevalin litigation would deal with the questions of whether the product was defective and whether the manufacturer and distributors were honest in informing officials, health care providers, and the public about the drug and its dangers.
In the case of Zevalin, the manufacturer, Biogen Idec, revealed in 2005 that the drug had produced serious and sometimes fatal skin conditions, a danger that was unknown to the FDA, health care providers, and the public. Patients who suffered these skin reactions or the families of those who died from these reactions may be able to recover damages from Biogen Idec. No Zevalin cases have been reported at this time. If you or a family member has been injured by Zevalin, you need to have your case evaluated by an experienced and qualified Zevalin attorney. See Hiring a Zevalin Attorney and Lawyer to find a Zevalin specialist who can help you.
Check out the following articles for more information about Zevalin, filing an Zevalin lawsuit and finding an Zevalin attorney.